JP2010530362A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010530362A5 JP2010530362A5 JP2010510239A JP2010510239A JP2010530362A5 JP 2010530362 A5 JP2010530362 A5 JP 2010530362A5 JP 2010510239 A JP2010510239 A JP 2010510239A JP 2010510239 A JP2010510239 A JP 2010510239A JP 2010530362 A5 JP2010530362 A5 JP 2010530362A5
- Authority
- JP
- Japan
- Prior art keywords
- hpv
- amino acid
- derived
- protein
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94107007P | 2007-05-31 | 2007-05-31 | |
| EP07109287 | 2007-05-31 | ||
| PCT/NL2008/050315 WO2009002159A2 (en) | 2007-05-31 | 2008-05-27 | Intradermal hpv peptide vaccination |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014133168A Division JP5888823B2 (ja) | 2007-05-31 | 2014-06-27 | 皮内ｈｐｖペプチドワクチン接種 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010530362A JP2010530362A (ja) | 2010-09-09 |
| JP2010530362A5 true JP2010530362A5 (https=) | 2011-06-30 |
Family
ID=38477016
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510239A Pending JP2010530362A (ja) | 2007-05-31 | 2008-05-27 | 皮内ｈｐｖペプチドワクチン接種 |
| JP2014133168A Expired - Fee Related JP5888823B2 (ja) | 2007-05-31 | 2014-06-27 | 皮内ｈｐｖペプチドワクチン接種 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014133168A Expired - Fee Related JP5888823B2 (ja) | 2007-05-31 | 2014-06-27 | 皮内ｈｐｖペプチドワクチン接種 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9562075B2 (https=) |
| EP (1) | EP2155240B1 (https=) |
| JP (2) | JP2010530362A (https=) |
| CN (1) | CN101795705A (https=) |
| AU (1) | AU2008269721B2 (https=) |
| BR (1) | BRPI0812311A8 (https=) |
| CA (1) | CA2688589A1 (https=) |
| ES (1) | ES2482192T3 (https=) |
| MX (1) | MX2009012922A (https=) |
| WO (1) | WO2009002159A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101765607B (zh) * | 2007-05-31 | 2015-09-09 | 莱顿教学医院 | 侵润宫颈恶性肿瘤的t细胞所靶向的用于疫苗的hpv表位 |
| EP2344191A4 (en) * | 2008-09-02 | 2013-02-13 | Antigen Express Inc | HUMAN PAPILLOMAVIRUS / LI-KEY HYBRIDS AND METHODS OF USE |
| US9550811B2 (en) | 2010-12-02 | 2017-01-24 | Bionor Immuno As | Peptide scaffold design |
| EP2883550A1 (en) * | 2013-12-12 | 2015-06-17 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Novel promiscuous HPV16-derived T helper epitopes for immunotherapy |
| EP3368051B1 (en) | 2015-10-30 | 2026-04-15 | Children's National Medical Center | Generating hpv antigen-specific t cells from a naive t cell population |
| EP3377099A4 (en) | 2015-11-18 | 2019-07-24 | ImmunoVaccine Technologies Inc. | ADJUVANT SYSTEMS AND WATER-FREE VAPOR COMPOSITION OF ONE POLYI: C-POLYNUCLEOTIDADJUVANS AND ADJUVANS ON LIPID BASE |
| KR20190020098A (ko) * | 2016-06-20 | 2019-02-27 | 아이에스에이 파마슈티컬즈 비.브이. | 펩타이드 백신의 제형 |
| WO2019099723A2 (en) * | 2017-11-15 | 2019-05-23 | Arizona Board Of Regents On Behalf Of Arizona State University | Materials and methods relating to immunogenic epitopes from human papillomavirus |
| US12599656B2 (en) * | 2018-03-12 | 2026-04-14 | Stemcell Technologies Canada Inc. | Methods for treating HPV-associated diseases |
| EP3765068A2 (en) * | 2018-03-12 | 2021-01-20 | SQZ Biotechnologies Company | Intracellular delivery of biomolecules to modify immune response |
| MA52363A (fr) * | 2018-04-26 | 2021-03-03 | Agenus Inc | Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation |
| US20220233676A1 (en) * | 2020-12-29 | 2022-07-28 | Sqz Biotechnologies Company | Formulations of activating antigen carriers |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus |
| US5180806A (en) * | 1988-05-16 | 1993-01-19 | The Scripps Research Institute | Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods |
| US5932412A (en) | 1990-05-11 | 1999-08-03 | Euro-Diagnostica Ab | Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes |
| DE9106105U1 (de) | 1991-05-17 | 1991-11-07 | Behringwerke Ag, 3550 Marburg | Diagnose-Kit zum Nachweis von Human-Papillomavirusinfektionen |
| US6419931B1 (en) | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
| GB9505784D0 (en) * | 1995-03-22 | 1995-05-10 | Lynxvale Ltd | Anti-tumour treatment |
| JP2000503003A (ja) * | 1995-12-22 | 2000-03-14 | イムノメディクス，インコーポレイテッド | 多段階カスケード増強ワクチンの効果を高めるための免疫接合体の使用 |
| ES2330017T3 (es) | 1998-05-23 | 2009-12-03 | Leiden University Medical Center | Ligandos de cd40 y peptidos de ctl para tratar tumores. |
| US20030118588A1 (en) | 1999-05-22 | 2003-06-26 | Linda Diehl | Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40 |
| US6641994B2 (en) * | 1999-08-25 | 2003-11-04 | Pharmacia & Upjohn Company | Methods of identifying anti-viral agents |
| US20020044948A1 (en) * | 2000-03-15 | 2002-04-18 | Samir Khleif | Methods and compositions for co-stimulation of immunological responses to peptide antigens |
| AU2002219711B8 (en) | 2000-12-08 | 2006-03-02 | Academisch Ziekenhuis Leiden | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| EP1417353A4 (en) * | 2001-07-20 | 2005-08-03 | Univ Texas | METHODS AND COMPOSITIONS ASSOCIATED WITH HPV ASSOCIATED PENCILS AND CANNULAR WELLS, INCLUDING CIN |
| US6884605B2 (en) * | 2001-08-09 | 2005-04-26 | Board Of Trustees Of The University Of Arkansas | Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer |
| JP5030594B2 (ja) | 2003-12-23 | 2012-09-19 | アルボー ビータ コーポレーション | Ｈｐｖの発癌性株に対する抗体およびそれらの使用方法 |
| JP2007528838A (ja) * | 2003-12-24 | 2007-10-18 | ライデン ユニバーシティ メディカル センター | 腫瘍特異的ワクチンとしての合成タンパク質 |
| US8252893B2 (en) | 2005-01-31 | 2012-08-28 | Board Of Trustees Of The University Of Arkansas | CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof |
| DE602006021408D1 (de) * | 2005-04-27 | 2011-06-01 | Univ Leiden Medical Ct | Behandlung von hpv-induzierter intraepithelialer anogenitaler neoplasien |
| AR054822A1 (es) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
-
2008
- 2008-05-27 ES ES08753797.3T patent/ES2482192T3/es active Active
- 2008-05-27 EP EP08753797.3A patent/EP2155240B1/en not_active Not-in-force
- 2008-05-27 BR BRPI0812311A patent/BRPI0812311A8/pt not_active IP Right Cessation
- 2008-05-27 MX MX2009012922A patent/MX2009012922A/es active IP Right Grant
- 2008-05-27 US US12/451,983 patent/US9562075B2/en not_active Expired - Fee Related
- 2008-05-27 CA CA002688589A patent/CA2688589A1/en not_active Abandoned
- 2008-05-27 WO PCT/NL2008/050315 patent/WO2009002159A2/en not_active Ceased
- 2008-05-27 CN CN200880101172A patent/CN101795705A/zh active Pending
- 2008-05-27 JP JP2010510239A patent/JP2010530362A/ja active Pending
- 2008-05-27 AU AU2008269721A patent/AU2008269721B2/en not_active Ceased
-
2014
- 2014-06-27 JP JP2014133168A patent/JP5888823B2/ja not_active Expired - Fee Related
-
2016
- 2016-12-16 US US15/381,367 patent/US20170143818A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010530362A5 (https=) | ||
| Wu et al. | Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation | |
| Meyer et al. | Clinical investigations of Toll-like receptor agonists | |
| Lin et al. | Therapeutic hpv DNA vaccines | |
| CN101528255A (zh) | Hpv抗原融合蛋白疫苗组合物及其应用 | |
| JP6811014B2 (ja) | Ｂ型肝炎ウイルスに対するワクチン | |
| Zhang et al. | Effects of astragalus polysaccharide on the immune response to foot-and-mouth disease vaccine in mice | |
| CN1678344A (zh) | 人乳头状瘤病毒治疗 | |
| WO2003090686A3 (en) | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality | |
| US10233215B2 (en) | Peptide and use thereof | |
| JP2009541373A5 (https=) | ||
| JP2026063187A (ja) | Ｉ型インターフェロン遺伝子を刺激するための方法及びカチオン性脂質を含む組成物 | |
| JP2014508734A5 (https=) | ||
| JP2021516991A5 (https=) | ||
| WO2005060993A1 (en) | Synthetic protein as tumor-specific vaccine | |
| JP2022172244A5 (https=) | ||
| Tseng et al. | Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination | |
| JP2010506926A5 (https=) | ||
| US8470372B2 (en) | Material with immunogenicity | |
| Peng et al. | Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines | |
| KR100904844B1 (ko) | 인유두종 바이러스（ｈｐｖ）유전자를 포함하는자궁경부암의 치료 또는 예방용 ｄｎａ 백신 | |
| CN105732780B (zh) | 一种枯草颖肽素及其应用 | |
| RU2006119462A (ru) | Применение специфических гистонов при лечении паразитарных заболеваний | |
| JP6663438B2 (ja) | 癌および皮膚病変の治療 | |
| JP2007505601A5 (https=) |